


There is no fund objective available from this fund manager.
| Name | % Net Assets |
|---|---|
| Total | 5.4% |
| Nestle | 4.6% |
| Sanofi-Aventis | 3.5% |
| Novartis | 3.2% |
| Roche | 3.2% |
| UBS | 3.0% |
| Atlas Copco | 2.7% |
| GBL | 2.5% |
| Svenska Handelsbanken | 2.5% |
| Sofina | 2.4% |
| Key | % Net Assets |
|---|---|
| 5.4% | |
| 4.6% | |
| 3.5% | |
| 3.2% | |
| 83.3% |
| Date | 20-Aug-2025 |
|---|---|
| NAV | 3,327.00p |
| Currency | GBP |
| Change | 0.000p |
| % | n/a |
| YTD change | 232.00p |
| YTD % | 7.50% |
| Fund Inception | n/a |
|---|---|
| Fund Manager | Angus Franklin / John Burke / Peter Hollis |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | n/a |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | n/a |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.02 |
| Sharpe ratio | 0.09 |
You are here: research